Xoma Ltd. (NASDAQ: XOMA) is surging on patent news this morning: “XOMA Issued Two New U.S. Patents for Methods of Treating Type 2 Diabetes and Inflammatory Diseases Using Interleukin-1 Beta Antibodies.â€Â At 8:52 AM EST we have seen 951,000 shares trade hands and the stock is up about 20.5% at $0.82. The 52-week trading range is $0.40 to $1.34.
JON OGG
